Work

Pharmacodynamically guided dose selection of PF-00337210, a VEGFR2 tyrosine kinase (TK) inhibitor, in a phase I study.

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.3033

Authors: G. Liu, P. LoRusso, E. I. Heath, J. Y. Bruce, A. M. Traynor, M. Pilat, A. Breazna, M. Tortorici, D. R. Shalinsky, A. D. Ricart

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2300723499

Cites:

Cited by:

Related to: 10